Related references
Note: Only part of the references are listed.FGFR3-TACC3: a novel gene fusion in malignant melanoma
Jiyun Lee et al.
PRECISION AND FUTURE MEDICINE (2018)
FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry
Yanyan Wang et al.
ONCOTARGETS AND THERAPY (2017)
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma
Koos Koole et al.
CANCER MEDICINE (2016)
FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer
Willemijn S. M. E. Theelen et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Targeting FGFR Signaling in Cancer
Mehdi Touat et al.
CLINICAL CANCER RESEARCH (2015)
Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations
Leandro H. Gallo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis
Guang-Wei Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFkB Signaling in Multiple Myeloma and Bladder Cancer
Lisa Salazar et al.
PLOS ONE (2014)
TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways
Geun-Hyoung Ha et al.
CANCER LETTERS (2013)
Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in FGFR3-Mutant Cancer
Maria Teresa Herrera-Abreu et al.
CANCER DISCOVERY (2013)
Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation
Dianbo Yao et al.
MOLECULAR CANCER RESEARCH (2011)
Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion Role of EMT promoting Smad complexes
Jonas Fuxe et al.
CELL CYCLE (2010)
A new understanding in the epidemiology of melanoma
Esther Erdei et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Cadherin Switching and Bladder Cancer
Richard T. Bryan et al.
JOURNAL OF UROLOGY (2010)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
Growth factors and receptors as prognostic markers in urothelial carcinoma
Peter C. Black et al.
Current Urology Reports (2008)
Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations
Kerstin Junker et al.
NEOPLASIA (2008)
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
Margaret A. Knowles
WORLD JOURNAL OF UROLOGY (2007)
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
D. C. Tomlinson et al.
JOURNAL OF PATHOLOGY (2007)
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
Richard Grose et al.
EMBO JOURNAL (2007)
Recurrent FGFR 1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)
Kolja Freier et al.
ORAL ONCOLOGY (2007)
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi
Christian Hafner et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
S. Streit et al.
BRITISH JOURNAL OF CANCER (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Structural basis for fibroblast growth factor receptor activation
M Mohammadi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients
ON Onwuazor et al.
BLOOD (2003)
Epithelial growth factor receptor interacting agents
J Baselga et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2002)
The enigma of ectopic expression of FGFR3 in multiple myeloma:: a critical initiating event or just a target for mutational activation during tumor progression
M Chesi et al.
CURRENT OPINION IN HEMATOLOGY (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
